We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
(+16%)
Cap. Flow
+$7.6B
Cap. Flow
% of AUM
5.51%
Top 10 Holdings %
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.28B |
| 2 |
Microsoft
MSFT
|
+$517M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$351M |
| 4 |
Apple
AAPL
|
+$302M |
| 5 |
Wells Fargo
WFC
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$685M |
| 2 |
Vanguard Extended Market ETF
VXF
|
+$566M |
| 3 |
Entergy
ETR
|
+$367M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$340M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.22% |
| 2 | Technology | 11.9% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 7.32% |
| 5 | Communication Services | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Globalstar
GSAT
$10.7B
| $136K | ﹤0.01% |
17,512
+217
| +1% | +$1.31K |
|
|
IVAC
3927
DELISTED
Intevac Inc
IVAC
| $136K | ﹤0.01% |
+19,319
| New | +$113K |
|
|
FRBK
3928
DELISTED
Republic First Bancorp Inc
FRBK
| $136K | ﹤0.01% |
32,676
-5,931
| -15% | -$24K |
|
3929
Lexicon Pharmaceuticals
LXRX
$1.03B
| $134K | ﹤0.01% |
32,202
+5,853
| +22% | +$22.5K |
|
3930
Quad
QUAD
$536M
| $132K | ﹤0.01% |
28,421
+7,678
| +37% | +$48K |
|
|
THBRW
3931
CALL
DELISTED
Thunder Bridge Acquisition II, Ltd. Warrants
THBRW
| $132K | ﹤0.01% |
+147,109
| New | +$131K |
|
|
AGNT
3932
AGNT Inc
AGNT
$666M
| $130K | ﹤0.01% |
22,928
-252
| -1% | -$1.25K |
|
|
UBX
3933
DELISTED
Unity Biotechnology
UBX
| $129K | ﹤0.01% |
1,799
+309
| +21% | +$21.8K |
|
|
NPTN
3934
DELISTED
NEOPHOTONICS CORP
NPTN
| $125K | ﹤0.01% |
+14,167
| New | +$106K |
|
|
ONDK
3935
DELISTED
On Deck Capital, Inc.
ONDK
| $122K | ﹤0.01% |
29,557
-4,569
| -13% | -$18.4K |
|
3936
PUT
Virgin Galactic
SPCE
$328M
| $116K | ﹤0.01% |
+500
| New | +$97.6K |
|
3937
Vertiv
VRT
$93B
| $116K | ﹤0.01% |
+10,500
| New | +$110K |
|
3938
Arcus Biosciences
RCUS
$3.55B
| $115K | ﹤0.01% |
11,422
-5,842
| -34% | -$49.1K |
|
3939
Ranpak Holdings
PACK
$438M
| $114K | ﹤0.01% |
+14,000
| New | +$89.6K |
|
3940
Standard BioTools
LAB
$340M
| $113K | ﹤0.01% |
32,432
-11,767
| -27% | -$41.4K |
|
|
VNTR
3941
DELISTED
Venator Materials PLC
VNTR
| $108K | ﹤0.01% |
28,425
-244,783
| -90% | -$796K |
|
|
HPR
3942
DELISTED
HighPoint Resources Corporation
HPR
| $108K | ﹤0.01% |
1,284
-1,088
| -46% | -$70.8K |
|
3943
Energous
WATT
$77.6M
| $107K | ﹤0.01% |
101
-7
| -6% | -$10.4K |
|
3944
Prospect Capital
PSEC
$1.07B
| $106K | ﹤0.01% |
16,421
+3,774
| +30% | +$24.6K |
|
|
HIL
3945
DELISTED
Hill International, Inc. Common Stock
HIL
| $106K | ﹤0.01% |
+33,604
| New | +$100K |
|
|
OPTN
3946
DELISTED
OptiNose
OPTN
| $103K | ﹤0.01% |
739
-293
| -28% | -$38K |
|
|
WOW
3947
DELISTED
WideOpenWest
WOW
| $103K | ﹤0.01% |
13,879
+1,744
| +14% | +$11K |
|
3948
Wave Life Sciences
WVE
$1.09B
| $103K | ﹤0.01% |
12,870
-1,287
| -9% | -$31.6K |
|
|
VBIV
3949
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $102K | ﹤0.01% |
2,453
+1,780
| +264% | +$39K |
|
|
RRTS
3950
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $102K | ﹤0.01% |
+11,102
| New | +$108K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q4 2019 Portfolio in Review
As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.
- Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
- Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
- Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
- Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
- Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
- Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
- Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.
Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.